Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function☆
References (16)
- et al.
Coronary heart disease and atrial fibrillation: the Framingham Study
Am Heart J
(1983) - et al.
The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm
J Am Coll Cardiol
(1990) - et al.
Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs
J Am Coll Cardiol
(1990) - et al.
Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan
Circulation
(1965) Atrial fibrillation revisited
N Engl J Med
(1982)Atrial Fibrillation. Etiology, Course, and Prognosis: A Follow- Up Study of 1212 Cases
(1975)- et al.
Clinical features of paroxysmal atrial fibrillation. An observation of 94 patients
Jpn Heart J
(1981) - et al.
Paroxysmal auricular fibrillation. A record of two hundred patients
Q J Med
(1930)
Cited by (148)
Atrial fibrillation in women
2023, Principles of Gender-Specific Medicine: Sex and Gender-Specific Biology in the Postgenomic EraSafety and long-term outcomes of catheter ablation according to sex in patients with atrial fibrillation: A nationwide cohort study
2021, International Journal of CardiologyCitation Excerpt :Likewise, despite higher rates of adverse reactions to antiarrhythmic drugs in women, they are less likely to undergo catheter ablations [6]. Therefore, female patients exhibit more symptoms than males and are less likely to respond to pharmacologic therapy [7–10]. AF ablation is more effective than antiarrhythmic drug therapy alone.
Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort
2018, International Journal of CardiologyCitation Excerpt :Consequently, women with HFpEF may be more intolerant of AF compared to men, a notion supported by the observation in I-PRESERVE that AF conferred an increased mortality risk in women compared to men [45]. For this reason, coupled with the fact that women are less likely to respond to pharmacologic therapy [46–49], providers may more likely pursue DCCV or catheter-ablation as a rhythm control strategy for women with HFpEF. While the impact of AF on long-term outcomes among patients with heart failure is well-described, its impact on short-term hospital outcomes is poorly characterized.
The Sexually Dimorphic Characteristics of the Pathophysiology and Treatment of Atrial Fibrillation
2017, Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third EditionGender Differences in Clinical Outcomes After Catheter Ablation of Atrial Fibrillation
2016, JACC: Clinical ElectrophysiologySimultaneous pulmonary vein cryoablation and cavotricuspid isthmus radiofrequency ablation in patients with combined atrial fibrillation and typical atrial flutter
2015, Journal of ElectrocardiologyCitation Excerpt :The common combination of atrial fibrillation (AF) and spontaneous or drug-induced atrial flutter (AFL) has long been reported [1–3]. Both, AF and AFL, are often resistant to antiarrhythmic drug therapy aimed at maintaining sinus rhythm [4]. Consequently, catheter ablation techniques are increasingly offered to drug-resistant patients.
- ☆
This study was presented in part at the 41st Annual Scientific Session of the American College of Cardiology, April 12–16, 1992, Dallas, Texas.